Bowel And Bladder Function in Infant Toilet Training

NCT04082689 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 293

Last updated 2025-02-21

No results posted yet for this study

Summary

The overall purpose is to assess whether assisted infant toilet training during the first year of life can prevent functional gastrointestinal and urinary tract disorders up to 4 year of age. Healthy Swedish children will be randomized to start assisted infant toilet training at 0-2 months of age or at 10-11 months of age.

The toilet training process will be described including mother-to-infant attachment and parental stress.

Conditions

  • Infantile Colic
  • Constipation - Functional
  • Bladder Dysfunction
  • Toilet Training

Interventions

BEHAVIORAL

Assisted Infant Toilet Training

The parents learn to sensitively respond to the child's routines and signals of elimination needs.The child's ability to convey the need for bowel and bladder evacuation is enhanced through responsive interaction so that a kind of assisted dryness is developed. The infant is held "squatting" over a potty or basin, while older children sit on the potty.

Sponsors & Collaborators

  • Center for Clinical Research Dalarna, Sweden

    collaborator OTHER
  • Örebro University, Sweden

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Dalarna County Council, Sweden

    lead OTHER

Principal Investigators

  • Barbro Hedin Skogman, assoc. prof. · Dalarna County Council, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-18
Primary Completion
2022-06-30
Completion
2025-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082689 on ClinicalTrials.gov